Treatment of Kaposi's sarcoma with ICRF-159 (NSC-129943).
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D006801:Humans; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011929:Razoxane / Q000627:therapeutic use*; D012514:Sarcoma, Kaposi / Q000188:drug therapy*
D010879:Piperazines; D011929:Razoxane